Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: J Hypertens. 2013 Feb;31(2):321–332. doi: 10.1097/HJH.0b013e32835b50aa

FIGURE 2.

FIGURE 2

Urinary albumin excretion (a and c) and kidney tubulointerstitial injury (b and d) in indole-3-carbinol (I3C)-induced and noninduced Cyp1a1-Ren-2 transgenic rats and the effects of isolated cis-4-[4-(3-adamantan-1-yl-ureido)cyclohexyloxy]benzoic acid (c-AUCB) or Nω-nitro-l-arginine methyl ester (L-NAME) administration and either combined treatment with c-AUCB and L-NAME or combined RAS blockade and Nω-nitro-l-arginine methyl ester (L-NAME) treatment in these rats. *P < 0.05 vs. unmarked values. #P < 0.05 vs. all values.